Blood pressure medicine recalled over high levels – Business News
More than half a million bottles of blood pressure remedy have been recalled over high levels of a chemical compound that might trigger most cancers, the Food and Drug Administration stated.
Parsippany, NJ-based Teva Pharmaceuticals USA recalled 580,844 bottles of Prazosin Hydrochloride earlier this month.
The remedy is an alpha blocker taken to decrease high blood pressure.
More than half a million bottles of blood pressure remedy have been recalled. Teva Pharmaceuticals
Testing revealed high levels of “N-nitroso Prazosin impurity C” within the drug, the FDA stated. Teva Pharmaceuticals
Testing revealed high levels of “N-nitroso Prazosin impurity C” within the drug, the FDA stated final week.
The chemical’s focus was so high that it surpassed the FDA’s security limits for its potential to trigger most cancers.
Different variations of the drug – together with 1 mg, 2 mg and 5 mg doses – have been included within the recall affecting bottles with anyplace from 100 to 1,000 capsules.
The FDA just lately categorised the recall as Class II, which is the second-highest of three risk levels.
A Class II label signifies that use of the remedy “may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” in accordance with the company.
“This recall has been initiated in coordination with the FDA and to date Teva has not received any relevant complaints related to this product,” Teva Pharmaceuticals USA instructed The Post in a assertion.
“Prazosin is indicated for the treatment of hypertension, to lower blood pressure, and there are many alternative treatments available to patients.”
As of Thursday morning, the drugmaker apparently had not offered instructions on whether or not shoppers ought to toss or flip in bottles of the recalled product.
